The existing technology screens only specific areas of the virus, but the molecular diagnostic technology was designed to cause nucleic acid-binding reactions only when the COVID-19 RNA exists, enabling rapid detection.
目前的技术只筛选病毒的特定区域，但分子诊断技术是在新冠病毒 RNA 存在时才会引起核酸结合反应，因此可以达到快速检测的效果。